RNU6-615P

Across TCGA pan-cancer cohorts, RNU6-615P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-615P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-615P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-615P expression acts as an unfavorable survival marker, although some lineages such as ESCA and COAD show a favorable association.

ACC, LIHC, and LUAD are the cancer types where RNU6-615P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.624	<.001	81	view →
LIHC	OS	Tertile	II,III,IV	0.157	0.782	<.001	45	view →
LUAD	OS	Tertile	III,IV	0.004	0.665	<.001	36	view →
THYM	DFS	Tertile	II,III,IV	0.621	0.933	.009	18	view →
TGCT	DFS	Tertile	III,IV	0.017	0.923	.021	18	view →
ESCA	OS	Tertile	III,IV	0.678	0.336	.017	14	view →
COAD	DFS	Tertile	All	0.946	0.676	.025	12	view →
GBM	DFS	Tertile	All	0.066	0.292	<.001	9	view →
LUSC	OS	Tertile	All	0.965	0.750	.046	3	view →
STAD	OS	Quartile	II,III,IV	0.777	0.621	.028	2	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-615P–ACC (DFS)

Open the ACC breakdown →